Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Low-penetration genes might help personalize colorectal cancer prevention.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

A patient with complete hair loss regrew all her hair using tofacitinib.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.